Johnson & Johnson severs ties with Emergent Biosolutions over more trashed COVID vaccines

Johnson & Johnson announced it is severing ties with Gaithersburg-based Emergent Solutions after the pharmaceutical company was forced to destroy another 135 million doses of its COVID-19 vaccine made at Emergent’s troubled Baltimore production plant because of quality issues. Congressional panel leaders announced the action Thursday, which follows a report in May that detailed how more than 400 million vaccine doses made at the plant had to be trashed. The doses more recently slated for destruction were made between August 2021 and February, the House members said.